Acadia Pharmaceuticals (ACAD) Gross Margin Growth (3y) (2019 - 2026)
Acadia Pharmaceuticals (ACAD) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 722.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -191.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -162.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -40.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | -784.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -784.00 |
| Dec 31, 2025 | -747.00 |
| Sep 30, 2025 | -613.00 |
| Jun 30, 2025 | -586.00 |
| Mar 31, 2025 | -579.00 |
| Dec 31, 2024 | -18.00 |
| Sep 30, 2024 | -473.00 |
| Jun 30, 2024 | -534.00 |
| Mar 31, 2024 | -910.00 |
| Dec 31, 2023 | -567.00 |
| Sep 30, 2023 | -524.00 |
| Jun 30, 2023 | -188.00 |
| Mar 31, 2023 | 170.00 |
| Dec 31, 2022 | 130.00 |
| Sep 30, 2022 | 92.00 |
| Jun 30, 2022 | 157.00 |
| Mar 31, 2022 | 213.00 |
| Dec 31, 2021 | -348.00 |
| Sep 30, 2021 | 378.00 |
| Jun 30, 2021 | 405.00 |